Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Izumi T and Shimizu T Platelet-activating factor receptor: gene expression and signal transduction. 1995 Biochim. Biophys. Acta pmid:8541341
Ramesha CS and Pickett WC Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells. 1987 Biochim. Biophys. Acta pmid:3113489
Qu XW et al. Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. 1999 Biochim. Biophys. Acta pmid:10446403
Shaw JO et al. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). 1981 Biochim. Biophys. Acta pmid:7213765
Kawaguchi H et al. Mechanism of increased angiotensin-converting enzyme activity stimulated by platelet-activating factor. 1990 Biochim. Biophys. Acta pmid:2162220
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Kumar R et al. Metabolism of platelet-activating factor (alkylacetylphosphocholine) by type-II epithelial cells and fibroblasts from rat lungs. 1987 Biochim. Biophys. Acta pmid:3790610
Vallee RB et al. The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. 2000 Biochim. Biophys. Acta pmid:10722879
Wheelan P and Clay KL Albumin and fatty acid effects on the stimulated production of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) by human polymorphonuclear leukocytes. 1992 Biochim. Biophys. Acta pmid:1511005
Dumas E et al. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. 2012 Biochim. Biophys. Acta pmid:22198097
Svetlov SI et al. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. 1997 Biochim. Biophys. Acta pmid:9219895
Ninio E et al. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. 1982 Biochim. Biophys. Acta pmid:7055592
Hopkins NK et al. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. 1983 Biochim. Biophys. Acta pmid:6313071
Winkler JD et al. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. 1997 Biochim. Biophys. Acta pmid:9219900
Clay KL et al. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells. 1991 Biochim. Biophys. Acta pmid:1909182
McCall MR et al. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. 1999 Biochim. Biophys. Acta pmid:9931415
Sugiura T et al. Ether phospholipids in guinea pig polymorphonuclear leukocytes and macrophages. Occurrence of high levels of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine. 1982 Biochim. Biophys. Acta pmid:7126622
Renooij W and Snyder F Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. 1981 Biochim. Biophys. Acta pmid:6260215
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Dupuis F et al. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. 1997 Biochim. Biophys. Acta pmid:9434130
Subramanian VS et al. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. 1999 Biochim. Biophys. Acta pmid:10395969
Careaga-Houck M and Sprecher H Effects of a fish oil diet on the metabolism of endogenous (n-6) and (n-3) fatty acids in rat neutrophils. 1990 Biochim. Biophys. Acta pmid:2174263
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
Sturk A et al. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. 1989 Biochim. Biophys. Acta pmid:2512985
Kloprogge E et al. Stimulus-aggregation coupling in platelets activated with PAF-acether. 1986 Biochim. Biophys. Acta pmid:3089297
Leyravaud S and Benveniste J Regulation of cellular retention of paf-acether by extracellular pH and cell concentration. 1989 Biochim. Biophys. Acta pmid:2775773
Gora S et al. The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2. 2006 Biochim. Biophys. Acta pmid:16962371
Bauldry SA and Wooten RE Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. 1996 Biochim. Biophys. Acta pmid:8816854
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Hirafuji M et al. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. 1987 Biochim. Biophys. Acta pmid:2888488
Siafaka-Kapadai A and Hanahan D An endogenous inhibitor of PAF-induced platelet aggregation, isolated from rat liver, has been identified as free fatty acid. 1993 Biochim. Biophys. Acta pmid:8382959
Sawyer DB and Andersen OS Platelet-activating factor is a general membrane perturbant. 1989 Biochim. Biophys. Acta pmid:2480815
Bette-Bobillo P et al. Interaction between blood components and a spin-labeled analogue of PAF-acether. 1986 Biochim. Biophys. Acta pmid:3017416
Touqui L et al. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. 1985 Biochim. Biophys. Acta pmid:3967037
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Baker RR and Chang H MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. 1998 Biochim. Biophys. Acta pmid:9630721
Kishino J et al. Synergistic effect of thromboxane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils. 1991 Biochim. Biophys. Acta pmid:1673352
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Flasiński M et al. Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs synthetic (ED) ether lipids on model lipid membranes. 2013 Biochim. Biophys. Acta pmid:23906729
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Bachelet M et al. Changes induced by PAF-acether in diacyl and ether phospholipids from guinea-pig alveolar macrophages. 1986 Biochim. Biophys. Acta pmid:3092866
Montero M et al. Comparative effects of cytochrome P-450 inhibitors on Ca2+ and Mn2+ entry induced by agonists or by emptying the Ca2+ stores of human neutrophils. 1993 Biochim. Biophys. Acta pmid:7684611
Alonso F et al. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. 1986 Biochim. Biophys. Acta pmid:3092867
Asmis R and Dennis EA PAF stimulates cAMP formation in P388D1 macrophage-like cells via the formation and secretion of prostaglandin E2 in an autocrine fashion. 1994 Biochim. Biophys. Acta pmid:7981245
Baker RR and Chang HY The potential for platelet-activating factor synthesis in brain: properties of cholinephosphotransferase and 1-alkyl-sn-glycero-3-phosphate acetyltransferase in microsomal fractions of immature rabbit cerebral cortex. 1993 Biochim. Biophys. Acta pmid:8399340
Tence M et al. The enantiomer and the positional isomer of platelet-activating factor. 1983 Biochim. Biophys. Acta pmid:6824744
Shaw JO and Lyons RM Requirements for different Ca2+ pools in the activation of rabbit platelets. I. release reaction and protein phosphorylation. 1982 Biochim. Biophys. Acta pmid:6800409
Bratton DL et al. A model for the extracellular release of PAF: the influence of plasma membrane phospholipid asymmetry. 1991 Biochim. Biophys. Acta pmid:1705442
Pelech SL et al. Protein kinase C activation by platelet-activating factor is independent of enzyme translocation. 1990 Biochim. Biophys. Acta pmid:2153414
Bonaccorsi L et al. Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. 1997 Biochim. Biophys. Acta pmid:9042336
Tokumura A et al. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. 1999 Biochim. Biophys. Acta pmid:10064906
Kimura Y et al. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes. 1987 Biochim. Biophys. Acta pmid:2825795
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Tokumura A et al. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes. 1990 Biochim. Biophys. Acta pmid:2340312
Tjoelker LW and Stafforini DM Platelet-activating factor acetylhydrolases in health and disease. 2000 Biochim. Biophys. Acta pmid:11080681
Dentan C et al. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase. 1996 Biochim. Biophys. Acta pmid:8597590
Dewald B and Baggiolini M Platelet-activating factor as a stimulus of exocytosis in human neutrophils. 1986 Biochim. Biophys. Acta pmid:3017443
Turner MR and Lumb RH Synthesis of platelet activating factor by tissues from the rainbow trout, Salmo gairdneri. 1989 Biochim. Biophys. Acta pmid:2742873
Kitagawa S et al. Inhibitory effects of phenol derivatives on bovine platelet aggregation and their effects on Ca2+ mobilization. 1989 Biochim. Biophys. Acta pmid:2493810
Sugiura T et al. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. 1999 Biochim. Biophys. Acta pmid:10521703
Leslie CC et al. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. 1988 Biochim. Biophys. Acta pmid:3143418
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Cabré F et al. Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2. 1992 Biochim. Biophys. Acta pmid:1576169
Jackson JR et al. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. 1998 Biochim. Biophys. Acta pmid:9593866
Amirkhanian JD and Taeusch HW Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. 1993 Biochim. Biophys. Acta pmid:8418890
Woodard DS et al. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride. 1995 Biochim. Biophys. Acta pmid:7488633
Kawaguchi H and Yasuda H Effect of platelet-activating factor on arachidonic acid metabolism in renal epithelial cells. 1986 Biochim. Biophys. Acta pmid:3081036
Bauldry SA et al. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. 1991 Biochim. Biophys. Acta pmid:1854803
Kester M et al. Alkylacetylglycerophosphocholine stimulates Na+-Ca2+ exchange, protein phosphorylation and polyphosphoinositide turnover in rat ileal plasmalemmal vesicles. 1986 Biochim. Biophys. Acta pmid:3019423
Fradin A et al. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. 1988 Biochim. Biophys. Acta pmid:2848583
Krishnamurthi S et al. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. 1987 Biochim. Biophys. Acta pmid:3101746
Remy E et al. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils. 1989 Biochim. Biophys. Acta pmid:2505852
Bussolino F et al. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. 1987 Biochim. Biophys. Acta pmid:3024738
Tanaka T et al. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. 1994 Biochim. Biophys. Acta pmid:8280771
van den Bosch H et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. 1993 Biochimie pmid:8507680
Tencé V et al. Release, purification, and characterization of platelet-activating factor (PAF). 1980 Biochimie pmid:17941181
Watschinger K and Werner ER Orphan enzymes in ether lipid metabolism. 2013 Biochimie pmid:22771767
Olivier JL et al. Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol. 1989 Biochimie pmid:2541796
Murakami M and Lambeau G Emerging roles of secreted phospholipase A(2) enzymes: an update. 2013 Biochimie pmid:23022039
Nankar SA et al. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. 2013 Biochimie pmid:23376877
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Grambow E et al. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity. 2016 Biofactors pmid:27151562
Yoshikawa T et al. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. 1998 Biofactors pmid:9523024
Zinchenko VP et al. [Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. 1997 Sep-Oct Biofizika pmid:9410037
Negresku EV et al. [Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. 1989 Biokhimiia pmid:2551395
Kuznetsova TI and Kulikov VI [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes]. 1992 Biokhimiia pmid:1327185
Kulikov VI and Bergel'son LD [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes]. 1984 Biokhimiia pmid:6093897
Kulikov VI et al. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. 1984 Biokhimiia pmid:6542803
Muzia GI et al. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells]. 1994 Biokhimiia pmid:7948414
Lichko LP et al. [The effect of PAF, sphingosine and heparin on certain phosphohydrolase and transport activity of yeast vacuoles]. 1994 Biokhimiia pmid:7948417
Kulikov VI and Muzia GI [Biological role of cellular metabolites--structural analogs of platelet activating factor]. 1996 Biokhimiia pmid:8724598
Muzia GI and Kulikov VI [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. 1996 Biokhimiia pmid:8724603
Kulikov VI and Muzia GI [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators]. 1992 Biokhimiia pmid:1420585
Muzia TI and Kulikov VN [1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine: acetylhydrolase is associated primarily with low density lipoproteins in human blood]. 1991 Biokhimiia pmid:1932343
Muzia GI et al. [Interaction of cells from murine organs with liposomes of various composition]. 1991 Biokhimiia pmid:1932348
Orlov SM et al. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. 1985 Biokhimiia pmid:2408682
Avdonin PV and Altukhova IP [Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. 1985 Biokhimiia pmid:2416359
Avdonin PV et al. [Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. 1985 Biokhimiia pmid:3000463